September Newsletter from BioMADE
Letter from the CEO
Dear BioMADE Stakeholders,
I’m writing today with an important update about our inaugural Annual Meeting.
After careful consideration and in light of the COVID-19 resurgence, we are scaling back our November meeting plans to a series of entirely online interactive sessions and Committee meetings. These activities will still take place Nov. 1-3, 2021. Topics will include BioMADE’s Transition Technical Roadmap, integrating Safety, Security, Sustainability, and Social Responsibility (4S) into BioMADE projects, and information about BioMADE’s first Roadmap-Directed Project Call, launching in October. There will also be plenty of time for engaging with each other.
BioMADE Committees will have their first meetings during this time. I encourage you to participate on a BioMADE Committee or Subcommittee, as it’s a great way to meet and collaborate with other BioMADE members and work together to guide BioMADE’s work. Joining a BioMADE Committee at this early stage will help ensure that your organization’s voice is heard as we develop a technical roadmap, identify our Education and Workforce Development strategy, set priorities, and make decisions.
If you’re not a member yet and want to be considered for this inaugural year of committee assignments, organizations need to be signed on as members by Tuesday, Oct. 5 at 12:00 noon CST. Please click here for more details about BioMADE’s Committees.
If you’re a current BioMADE member and haven’t yet confirmed your Committee nominations, please do so by Tuesday, Oct. 5. Reach out to email@example.com if you have any questions.
We wish we could see you all in person in Minneapolis this November, but are looking forward to robust virtual engagement. We hope to get together in-person for a full Annual Meeting in spring 2022!
Member Spotlight: University of California, Davis and Checkerspot
A unique partnership between BioMADE members is helping build and inspire the next generation of bioindustrial manufacturing leaders. Biochemical engineering students at the University of California, Davis recently participated in a unique, real-world capstone project during their senior year with Checkerspot, an Alameda-based company that biomanufactures unique structural oils.
Over the course of two quarters, students learned about a product they’re trying to make, the host organism, and what the production looks like, ultimately designing a biomanufacturing facility to produce said product. The model of the facility includes real specifications, like equipment sizes, material and energy balances, capital investments, and more.
“Every year, I look for company partners who will provide guidance and mentorship of our student teams,” said Dr. Karen McDonald, Professor of Chemical Engineering at UC-Davis. “BioMADE introduced us to Checkerspot who perfectly fit the bill. Students really benefited from the hands-on expertise and knowledge their team has.”
Bridging the gap between lab-scale research and at-scale manufacturing is a core part of BioMADE’s mission. Bioindustrial manufacturing is changing and evolving quickly; and connecting academia with industry is key to building a prepared workforce for the future.
“We were delighted to host UC-Davis students last semester,” said Scott Franklin, Co-Founder and Chief Scientific Officer for Checkerspot. “There are so many exciting opportunities in the bioindustrial manufacturing industry for recent graduates right now. All of these great new products and ideas will need pilot facilities, so students are learning really valuable skills.”
“Partnering with industry members also helps those of us on the academic side stay up to date on the latest in bioindustrial manufacturing technologies and processes,” added McDonald. “I’m grateful to BioMADE for bringing us all together across disciplines, and look forward to finding many more mutually beneficial collaboration opportunities in the future.”
New Paper: BioInspired, BioDriven, BioMADE: The U.S. Bioindustrial Manufacturing and Design Ecosystem as a driver of the 4th Industrial Revolution
BioMADE CEO Douglas Friedman and Government Program Manager Patrick Rose recently published a new paper on the promise of bioindustrial manufacturing and BioMADE’s role in the fourth industrial revolution.
“The key to getting behind the curtain and revealing the remaining unknowns in biology has been accelerated by advancements in engineering tools for harnessing biology. The last decade has been remarkable in science and technology advancements, which have given us many new and improved tools as well as novel insights into how we can translate such biological manufacturing efficiency to conventional industrial manufacturing for broad commercial consumption.” Click here to read the full paper.
Events and Opportunities
SBIR/STTR Opportunity: Next Generation Autonomous and Modular Hardware for Biomanufacturing Platforms in Remote Locations
The Defense Advanced Research Projects Agency (DARPA) Small Business Programs Office is issuing an SBIR/STTR Opportunity inviting submissions of innovative research concepts in the technical domain(s) of Materials/Processes. DARPA is particularly interested in understanding the feasibility of Next Generation Autonomous and Modular Hardware for Biomanufacturing Platforms in Remote Locations.
There is a critical Department of Defense need to increase readiness and technological superiority by enhancing in-situ manufacturing of DoD-relevant molecules to reduce supply chain vulnerabilities resulting from foreign dependencies for warfighter support in remote locations. Advances in the field of biomanufacturing and organism engineering have demonstrated that a wide array of mission-critical molecules can be made at industrially relevant titers from biology. For instance, engineered organisms capable of producing molecules such as insect repellants, fuels, polymer monomers, and lubricants could be stored with minimal footprints and cultured for on-demand molecule production. Proposals are due October 28, 2021. Learn more here.
Biotechnology COI Industry Engagement (IR&D TIM) December 6-9
Mark your calendars for the 2021 Biotechnology Independent Research and Development (IR&D) Technology Interchange Meeting (TIM) on December 6-9, 2021. This event is hosted by the Air Force IR&D Office in concert with DoD’s Biotechnology Community of Interest. This event is open to all industry with IR&D and corporate investments, including large and small businesses, academia, National Labs, and FFRDCs with a signed and certified DD2345 (Military Critical Technical Data Agreement).
The 2021 Biotechnology IR&D TIM has broad goals to increase awareness, stimulate collaboration, and seek alignment between Industry’s IR&D innovation investments and DoD’s high-priority S&T needs. Leading Subject Matter Experts (SMEs) from the Biotechnology CoI are expected to participate. Companies have until October 6 to provide an abstract nomination. Learn more here.
Government Contracting 101 – SAM Registration
SAM is an acronym for the System for Award Management. It is also a useful website that consolidates several Federal Government systems and is used to “collect, validate, store and disseminate business information…in support of the contract awards, grants and electronic payment processes.”
In order to be the recipient of a federal subaward you must have a completed, active SAM registration. Click here to start the process. Have questions about the process? Visit the Federal Service help desk here.